TERAVOLT: Thoracic Cancers International COVID-19 Collaboration

Jennifer G. Whisenant, Annalisa Trama, Valter Torri, Alessandro De Toma, Giuseppe Viscardi, Alessio Cortellini, Olivier Michielin, Fabrice Barlesi, Anne Marie C. Dingemans, Jan Van Meerbeeck, Vera Pancaldi, Ross A. Soo, Natasha B. Leighl, Solange Peters, Heather Wakelee, Marina Chiara Garassino, Leora Horn

    Research output: Contribution to journalComment/debate

    46 Citations (Scopus)

    Abstract

    Prior publications on small subsets of cancer patients infected with SARS CoV-2 have shown an increased risk of mortality compared to the general population. Furthermore, patients with thoracic malignancies are thought to be at particularly high risk given their older age, smoking habits, and pre-existing cardio-pulmonary comorbidities. For this reason, physicians around the world have formed TERAVOLT, a global consortium dedicated to understanding the impact of COVID-19 on patients with thoracic malignancies.

    Original languageEnglish
    Pages (from-to)742-745
    Number of pages4
    JournalCancer Cell
    Volume37
    Issue number6
    DOIs
    Publication statusPublished - 8 Jun 2020

    Cite this